Abstract:This study was purposed to comparatively analyze the early T-lymphocyte subsets and T-cell receptor excision cycles (TREC) reconstruction in recipients with hematologic malignancies after myeloablative unrelated cord blood transplantation (UCBT) and sibling donor bone marrow and/or peripheral blood stem cell transplantation (BMT/PBSCT). The peripheral blood T lymphocyte subsets were detected using flow cytometry and TREC were detected using real-time quantitative PCR for 40 patients with hematologic malignancies in the first six months after myeloablative allogenic hematopoietic stem cell transplantation. The results showed that in the first month after transplantation, the absolute counts of CD3(+), CD3(+) CD4(+), CD3(+) CD8(+) cells were lower significantly in the UCBT group than those in the BMT/PBSCT group. And later the absolute counts of CD3(+), CD3(+)CD4(+), CD3(+)CD8(+) cells were not different between two groups. The ratio of CD3(+)T subset in the peripheral blood lymphocytes of the UCBT recipients was lower, but the difference was not statistically significant within 2 months after transplantation. The ratio of CD3(+)CD4(+) cells in the patients received the UCBT and BMT/PBSCT decreased obviously since engraftment happened. The CD3(+)CD4(+) cells on the 2 months after transplantation fell to the lowest level, then gradually increased, but did not reach to the normal level until 6 months after transplantation. CD3(+)CD8(+)cells were well reconstituted, rising to normal at the engraftment after transplantation, with a low CD4(+): [KG-*2] CD8(+) ratio over the first 6 months after transplantation. Compared with the BMT/ PBSCT group, the naive T cells (CD3(+)CD4(+)CD45RA(+)CD62L(+)) were more in the first month after transplantation and the terminally differentiated effector memory T cells (CD3(+)CD4(+)CD45RA(+)CD62L(-)) were more at the 3 month after transplantation in the UCBT group, and those were significantly more than the normal control group. TREC were lower and did not recovered until 6 months after transplantation in the recipients of the two groups. It is concluded that compared with sibling donor's BMT/PBSCT, early T cell reconstitution significantly delayed after UCBT, but the terminally differentiated effector memory T cells are higher after transplantation, and thus play a anti-infective or anti-leukemia role.

The rule of hematopoiesis reconstruction after peripheral blood stem cell transplantation and analysis of the correlative factors

Allogeneic Peripheral Blood Stem Cell Transplantation for Leukemia

[Long Term Curative Effects and Prognostic Analysis of Stem Cell Transplantation for Treating Patients with Peripheral T Cell Lymphoma].

[Short-Term Effects of Hemogram in Healthy Donors after Peripheral Blood Stem Cell Collection].

[Hematopoietic Reconstitution on the Prognosis of Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation].

Immune Reconstitution after Allo-Peripheral Blood Hematopoietic Stem Cell Transplantation

Clinical Observation of Factors in the Efficacy of Blood Component Transfusion in Patients Following Hematopoietic Stem Cell Transplantation

[The kinetics and prognosis of platelet reconstitution after unmanipulated haploidentical stem cell transplantation without in vitro T cell depletion].

Experimental Study on Hematopoietic Reconstruction Effects of Peripheral Blood Stem Cells Mobilized by Anti-Cd49d Monoclonal Antibody Plus Rhg-Csf in Mice

[Allogeneic Peripheral Blood Stem Cell Transplantation in the Treatment of Hematologic Malignancies].

Analysis of 66 Cases Received Hematopoietic Stem Cell Transplantation from Unrelated Donors

Factors Influencing Engraftment in Hematological Patients after Human Leukocyte Antigen Matched Sibling Allogeneic Blood and Marrow Transplantation

Platelet Engraftment in Patients with Hematologic Malignancies Following Unmanipulated Haploidentical Blood and Marrow Transplantation: Effects of Cd34(+) Cell Dose and Disease Status

Allogeneic peripheral blood stem cell transplantation for 75 cases of hematologic malignancies]

STUDY ON THE RELATIONSHIP BETWEEN HEMATOPOIETIC GROWTH FACTOR ACTIVITIES IN THE PLASMA OF BONE MARROW TRANSPLANTATION RECIPIENTS AND HEMATOPOIETIC RECONSTRUCTION

Autologous Peripheral Blood Stem Cell Transplantation Is More Therapeutically Effective In The Patients With Hematologic And Solid Tumors.

Comparison of immune reconstitution after peripheral blood stem cell transplantation and umbilical cord blood transplantation

Impact of Pre-Transplantation Characteristics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies: a Retrospective Analysis of 100 Cases

Clinical efficacy of allogeneic hematopoietic stem cell transplantation on myelodysplastic syndrome

[Comparative Analysis of Early Reconstitution of T-lymphocyte Subsets and T-cell Receptor Excision Cycles in Patients after Myeloablative Unrelated Cord Blood and Sibling Donor Transplantation].

Clinical Study of G-CSF Mobilized Allogeneic Bone Marrow Cells Plus Peripheral Blood Stem Cells Transplantation for Hematological Diseases